Evaluation of prophylactic dosages of Enoxaparin in non-surgical elderly patients with renal impairment

BACKGROUND: Thromboprophylaxis dosing strategies using enoxaparin in elderly patients with renal disease are limited, while dose adjustments or monitoring of anti-Xa levels are recommended. We sought to evaluate the efficacy and safety of enoxaparin 20 mg versus 30 mg subcutaneously daily by compari...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:BMC Pharmacol Toxicol
Egile Nagusiak: Chamoun, Nibal, Ghanem, Hady, Hachem, Ahmad, Hariri, Essa, Lteif, Christelle, Mansour, Hanine, Dimassi, Hani, Zalloum, Richard, Ghanem, Georges
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2019
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6505244/
https://ncbi.nlm.nih.gov/pubmed/31064405
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40360-019-0308-8
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak